Oliveira, Erica Aparecida de 
; Goding, Colin R; Maria-Engler, Silvya Stuchi
Source: Organotypic Models in Drug Development. Unidade: FCF
Subjects: NEOPLASIAS, RESISTÊNCIA MICROBIANA ÀS DROGAS, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Erica Aparecida de e GODING, Colin R e MARIA-ENGLER, Silvya Stuchi. Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development. Organotypic Models in Drug Development. Tradução . Cham: Springer, 2021. . Disponível em: https://doi.org/10.1007/978-3-030-70063-8. Acesso em: 29 jun. 2024.APA
Oliveira, E. A. de, Goding, C. R., & Maria-Engler, S. S. (2021). Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development. In Organotypic Models in Drug Development. Cham: Springer. doi:10.1007/978-3-030-70063-8NLM
Oliveira EA de, Goding CR, Maria-Engler SS. Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development [Internet]. In: Organotypic Models in Drug Development. Cham: Springer; 2021. [citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/978-3-030-70063-8Vancouver
Oliveira EA de, Goding CR, Maria-Engler SS. Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development [Internet]. In: Organotypic Models in Drug Development. Cham: Springer; 2021. [citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/978-3-030-70063-8
